Epsilon Healthcare Ltd (EPN) - Total Assets

Latest as of December 2025: AU$17.87 Million AUD ≈ $12.64 Million USD

Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) holds total assets worth AU$17.87 Million AUD (≈ $12.64 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Epsilon Healthcare Ltd - Total Assets Trend (2016–2025)

This chart illustrates how Epsilon Healthcare Ltd's total assets have evolved over time, based on quarterly financial data. Also see EPN market cap overview for the company's overall valuation and market capitalisation.

Epsilon Healthcare Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Epsilon Healthcare Ltd's total assets of AU$17.87 Million consist of 29.5% current assets and 70.5% non-current assets. Review Epsilon Healthcare Ltd total liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$0.00 1.4%
Accounts Receivable AU$3.63 Million 20.3%
Inventory AU$1.20 Million 6.7%
Property, Plant & Equipment AU$12.16 Million 68.1%
Intangible Assets AU$0.00 0.0%
Goodwill AU$0.00 0.0%

Asset Composition Trend (2016–2025)

This chart illustrates how Epsilon Healthcare Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Epsilon Healthcare Ltd (EPN) share price today for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Epsilon Healthcare Ltd's current assets represent 29.5% of total assets in 2025, a decrease from 41.0% in 2016.
  • Cash Position: Cash and equivalents constituted 1.4% of total assets in 2025, down from 31.6% in 2016.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 58.0% in 2016.
  • Asset Diversification: The largest asset category is property, plant & equipment at 68.1% of total assets.

Epsilon Healthcare Ltd Competitors by Total Assets

Key competitors of Epsilon Healthcare Ltd based on total assets are shown below.

Company Country Total Assets
Viatris Inc
NASDAQ:VTRS
USA $35.04 Billion
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
China CN¥10.64 Billion
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
China CN¥4.70 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
China CN¥4.44 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
China CN¥10.37 Billion
Guangxi Wuzhou Zhongheng Group Co Ltd
SHG:600252
China CN¥10.29 Billion
Beijing Science Sun Pharmaceutical Co Ltd
SHE:300485
China CN¥3.60 Billion
Verano Holdings Corp
NEO:VRNO
Canada CA$1.70 Billion

Epsilon Healthcare Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.14 0.32 1.73
Quick Ratio 0.88 0.27 1.39
Cash Ratio 0.00 0.00 1.14
Working Capital AU$654.53K AU$-7.81 Million AU$4.46 Million

Epsilon Healthcare Ltd - Advanced Valuation Insights

This section examines the relationship between Epsilon Healthcare Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 4.88
Latest Market Cap to Assets Ratio 0.39
Asset Growth Rate (YoY) -19.7%
Total Assets AU$17.87 Million
Market Capitalization $6.88 Million USD

Valuation Analysis

Below Book Valuation: The market values Epsilon Healthcare Ltd's assets below their book value (0.39x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Epsilon Healthcare Ltd's assets decreased by 19.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Epsilon Healthcare Ltd (2016–2025)

The table below shows the annual total assets of Epsilon Healthcare Ltd from 2016 to 2025.

Year Total Assets Change
2025-12-31 AU$17.87 Million
≈ $12.64 Million
-19.74%
2024-12-31 AU$22.26 Million
≈ $15.75 Million
+54.46%
2023-12-31 AU$14.41 Million
≈ $10.20 Million
-29.70%
2022-12-31 AU$20.50 Million
≈ $14.51 Million
-32.90%
2021-12-31 AU$30.55 Million
≈ $21.62 Million
-18.01%
2020-12-31 AU$37.26 Million
≈ $26.37 Million
+33.97%
2019-12-31 AU$27.81 Million
≈ $19.68 Million
-15.06%
2018-12-31 AU$32.75 Million
≈ $23.17 Million
+49.21%
2017-12-31 AU$21.95 Million
≈ $15.53 Million
+91.50%
2016-12-31 AU$11.46 Million
≈ $8.11 Million
--

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic
Market Cap
$6.88 Million
AU$9.73 Million AUD
Market Cap Rank
#27975 Global
#1426 in Australia
Share Price
AU$0.03
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.04
All Time High
AU$1.08
About

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturi… Read more